These disorders may develop anytime during the course of the neoplastic disease. Serum and urine immunofixation studies should be considered in pts with peripheral neuropathy of unknown cause; detection of a monoclonal gammopathy suggests the need for additional studies to uncover a B cell or plasma cell malignancy. In paraneoplastic neuropathies, diagnostically useful antineuronal antibodies are limited to anti-CV2/CRMP5 and anti-Hu.
Myasthenia gravis is discussed in Chap. 194. Myasthenia Gravis and dermatomyositis in Chap. 195. Muscle Diseases.
Treatment: Paraneoplastic Neurologic Disorders
|
For a more detailed discussion, see Dalmau J, Rosenfeld MR: Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis, Chap. 122, p. 614, in HPIM-19. |
Section 6. Hematology and Oncology